Ann Intern Med August 2017 PMID 28738423

Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes: A Cohort Study.

Huabing Zhang, Jorge Plutzky, Maria Shubina, Alexander Turchin

Mentions

100
Peak: 2 in Feb 2023
across 5 sources since Sep 2021

Extended reach

93,122
potential audience

Total likes

218

Video views

3,393

Mentions per month

Sep 2021 – May 2025

Where it's discussed

  • News70 articles
  • Facebook17 posts
  • Blogs6 articles
  • X / Twitter5 posts
  • YouTube2 videos

AI synopsis

What people are saying

The discussions support the importance of the study by citing how stopping statins can lead to worse health outcomes, with posts like 'stopping statins leads to increased mortality.' At the same time, there are cautious responses criticizing the interpretation of small percentage differences as significant, indicating a balance of agreement with and skepticism toward the study's conclusions based on the tone and focus of the comments.

AgreementStrong agreement

Most discussions highlight the importance of continuing statins after adverse reactions, emphasizing their role in reducing mortality and cardiovascular issues.

InterestModerate interest

The topic of statin continuation and its implications naturally draws moderate interest, reflected in concerns about medical decisions and patient outcomes.

EngagementModerate engagement

Posts show some engagement by referencing the significance of the study, but limited detailed discussion or critique is present.

ImpactModerate impact

Participants recognize the potential impact of the findings on clinical practices, though skepticism about the interpretation of statistical significance tempers full enthusiasm.

Abstract in brief

  • The study found that patients who continued statin therapy after experiencing adverse reactions had a slightly lower risk (17% reduction) of cardiovascular events or death over four years compared to those who stopped using statins.
  • Most adverse reactions were identified through provider notes, and it was unclear if patients always took the medication as prescribed.
  • Continued statin use after adverse reactions was linked to better patient outcomes, but the actual risk of having more adverse reactions upon reusing statins could not be determined from the data.]

Top posts

Most liked on X and Bluesky
Christian Faaborg Andersen MD
@CFAndersenMD · X

6/ Why does it matter? Well, stopping statins leads to increased mortality and worse CV outcomes!

Jun 20, 2023 · 15 likes · 4 shares · 920 followers View post →
Solana
@Solanaenie · X

Otro ejemplo de una publicación "científica" en el cual interpretan que una diferencia del 1 o 2 % entre el grupo medicado y el no medicado es significativa, cuando es mínima . Las conclusiones no están alineadas con los datos objetivos https://t.co/9GogcoFtuW

Feb 6, 2023 · 2 likes · 1 share · 14,074 followers View post →
Joel "Heart Prevention" Kahn MD, FACC
@drjkahn · X

Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes: A Cohort Study https://t.co/fJLyXbsqZA

May 25, 2025 · 1 like · 32,243 followers View post →
CardioNerds
@CardioNerds · X

RT @CFAndersenMD: 6/ Why does it matter? Well, stopping statins leads to increased mortality and worse CV outcomes!

Jun 20, 2023 · 4 shares · 40,706 followers View post →

All mentions

Joel "Heart Prevention" Kahn MD, FACC
@drjkahn · X

Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes: A Cohort Study https://t.co/fJLyXbsqZA

May 25, 2025 · 1 like · 32,243 followers View post →
CardioNerds
@CardioNerds · X

RT @CFAndersenMD: 6/ Why does it matter? Well, stopping statins leads to increased mortality and worse CV outcomes!

Jun 20, 2023 · 4 shares · 40,706 followers View post →
Christian Faaborg Andersen MD
@CFAndersenMD · X

6/ Why does it matter? Well, stopping statins leads to increased mortality and worse CV outcomes!

Jun 20, 2023 · 15 likes · 4 shares · 920 followers View post →
Buru Irekia @ASKATASUNA
@IrekiaBuru · X

RT @Soly_1984: Otro ejemplo de una publicación "científica" en el cual interpretan que una diferencia del 1 o 2 % entre el grupo medicado y…

Feb 7, 2023 · 1 share · 1,766 followers View post →
Solana
@Solanaenie · X

Otro ejemplo de una publicación "científica" en el cual interpretan que una diferencia del 1 o 2 % entre el grupo medicado y el no medicado es significativa, cuando es mínima . Las conclusiones no están alineadas con los datos objetivos https://t.co/9GogcoFtuW

Feb 6, 2023 · 2 likes · 1 share · 14,074 followers View post →